Across TCGA pan-cancer cohorts, MIR509-2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR509-2’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR509-2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR509-2 is over-expressed in tumor.

KIRC and KIRP are the cancer types where MIR509-2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR509-2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.563	<.001	9	view →
KIRP	All	All	+0.418	.011	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR509-2 RNA expression & survival · all MIR509-2 data types